Invitae
Invitae Corp. is a biotechnology company that was created as a subsidiary of Genomic Health in 2010 and then spun-off in 2012.
Traded as | NYSE: NVTA |
|---|---|
| Industry | Genetic testing |
| Founded | 2010 |
| Headquarters | San Francisco, California, U.S. |
Key people | Kenneth D. Knight (CEO) |
| Revenue | US$279.6 million (2020) |
Net income | -US$608.9 million (2020) |
| Website | www |
In 2017, Invitae acquired Good Start Genetics and CombiMatrix. In 2020, Invitae announced the acquisition of ArcherDX for $1.4 billion. In 2021, Invitae announced the acquisition of health care AI startup Ciitizen for $325 million.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.